Status:
ACTIVE_NOT_RECRUITING
Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Focal Segmental Glomerulosclerosis
Nephrotic Syndrome
Eligibility:
All Genders
Brief Summary
The investigators are trying to learn more about the cause of kidney diseases such as Focal Segmental Glomerulosclerosis (FSGS) and Nephrotic syndrome by studying genetics. The investigators are inter...
Detailed Description
The investigators welcome anyone (with or without a family history) with unexplained, non syndromic FSGS, nephrotic syndrome, or proteinuria to join the study. Participation involves a saliva (or bloo...
Eligibility Criteria
Inclusion
- Subjects with FSGS (focal segmental glomerulosclerosis)
- Subjects with NS (nephrotic syndrome)
- Subjects with unexplained kidney failure (have had a transplant or on dialysis)
- Subjects with unexplained proteinuria
- Family members of a person with FSGS, NS, kidney failure, or unexplained protein in their urine
- Healthy volunteers
Exclusion
- Patients whose kidney disease is already explained by another syndrome such as (Branchio Oto Renal Syndrome or Alports syndrome)
- Patients who already know the genetic cause of their kidney disease
Key Trial Info
Start Date :
June 1 1996
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2035
Estimated Enrollment :
2050 Patients enrolled
Trial Details
Trial ID
NCT02194582
Start Date
June 1 1996
End Date
January 1 2035
Last Update
November 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BIDMC
Boston, Massachusetts, United States, 02215